|
![]() |
|
|
Diphenoxylate: profile and news
Fired campus bus driver had history of auto accidents Nov 16, 2005 HEALTH WARNINGS FOR TRAVELERS' Sep 13, 2005 Four Local Dentists Disciplined By Licensing Board Aug 4, 2005 Bonds' doc on probation, was disciplined twice May 5, 2005 Other information Indication For as adjunctive therapy in the management of diarrhea Pharmacology Diphenoxylate, an antidiarrheal, is effective as adjunctive therapy in the management of diarrhea. Diphenoxylate is rapidly and extensively metabolized in man by ester hydrolysis to diphenoxylic acid (difenoxine), which is biologically active and the major metabolite in the blood. Mechanism Of Action Diphenoxylate is an opiate receptor agonists that stimulate mu receptors in GI to decrease the peristalsis and constrict the sphincters. Diphenoxylate has a direct effect on circular smooth muscle of the bowel, that conceivably results in segmentation and prolongation of gastrointestinal transit time. The clinical antidiarrheal action of diphenoxylate may thus be a consequence of enhanced segmentation that allows increased contact of the intraluminal contents with the intestinal mucosa. Drug Category Narcotics; Antidiarrheals; Antiperistaltic; ATC:A07DA01 Brand Names/Synonyms Dea No. 9170; Difenossilato [Dcit]; Difenoxilato [Inn-Spanish]; Difenoxilato [Spanish]; Diphenoxalate; Diphenoxylate; Diphenoxylate Hydrochloride; Diphenoxylate-Atropine; Diphenoxylatum [Inn-Latin]; Diphenoxylatum [Latin]; HSDB 3067; Lomotil; R 1132; R-1132 Dosage Forms Oral Solution; Tablet Absorption 90% Interactions Interactions for Diphenoxylate: Known drug interactions include barbiturates, tranquilizers, and alcohol. Diphenoxylate HCl and atropine sulfate may interact with MAO inhibitors In studies with male rats, diphenoxylate hydrochloride was found to inhibit the hepatic microsomal enzyme system at a dose of 2 mg/kg/day. Therefore, diphenoxylate has the potential to prolong the biological half-lives of drugs for which the rate of elimination is dependent on the microsomal drug metabolizing enzyme system. Chemical IUPAC Name ethyl 1-(3-cyano-3,3-diphenyl-propyl)-4-phenyl-piperidine-4-carboxylate Chemical Formula C30H32N2O2 Half Life 12-14 hours Drug Type Approved Drug # Accession No APRD00366 CAS Registry Number 915-30-0 |
|
Home | About | Cancers | Treatment | Medications Copyright onconews.org 2005. All Rights Reserved. |